158 related articles for article (PubMed ID: 10859328)
1. Expression of bcl-X(L) restores cell survival, but not proliferation off effector differentiation, in CD28-deficient T lymphocytes.
Dahl AM; Klein C; Andres PG; London CA; Lodge MP; Mulligan RC; Abbas AK
J Exp Med; 2000 Jun; 191(12):2031-8. PubMed ID: 10859328
[TBL] [Abstract][Full Text] [Related]
2. Cutting edge: distinct motifs within CD28 regulate T cell proliferation and induction of Bcl-XL.
Burr JS; Savage ND; Messah GE; Kimzey SL; Shaw AS; Arch RH; Green JM
J Immunol; 2001 May; 166(9):5331-5. PubMed ID: 11313368
[TBL] [Abstract][Full Text] [Related]
3. Regulation of T cell activation by CD28 and CTLA4.
Noel PJ; Boise LH; Thompson CB
Adv Exp Med Biol; 1996; 406():209-17. PubMed ID: 8910687
[TBL] [Abstract][Full Text] [Related]
4. Death by neglect as a deletional mechanism of peripheral tolerance.
Bertolino P; Trescol-Biémont MC; Thomas J; Fazekas de St Groth B; Pihlgren M; Marvel J; Rabourdin-Combe C
Int Immunol; 1999 Aug; 11(8):1225-38. PubMed ID: 10421780
[TBL] [Abstract][Full Text] [Related]
5. T cell costimulation through CD28 depends on induction of the Bcl-xgamma isoform: analysis of Bcl-xgamma-deficient mice.
Ye Q; Press B; Kissler S; Yang XF; Lu L; Bassing CH; Sleckman BP; Jansson M; Panoutsakopoulou V; Trimble LA; Alt FW; Cantor H
J Exp Med; 2002 Jul; 196(1):87-95. PubMed ID: 12093873
[TBL] [Abstract][Full Text] [Related]
6. Critical role of TNF receptor type-2 (p75) as a costimulator for IL-2 induction and T cell survival: a functional link to CD28.
Kim EY; Teh HS
J Immunol; 2004 Oct; 173(7):4500-9. PubMed ID: 15383581
[TBL] [Abstract][Full Text] [Related]
7. CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation.
Sperling AI; Auger JA; Ehst BD; Rulifson IC; Thompson CB; Bluestone JA
J Immunol; 1996 Nov; 157(9):3909-17. PubMed ID: 8892622
[TBL] [Abstract][Full Text] [Related]
8. CD28 regulates the translation of Bcl-xL via the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway.
Wu LX; La Rose J; Chen L; Neale C; Mak T; Okkenhaug K; Wange R; Rottapel R
J Immunol; 2005 Jan; 174(1):180-94. PubMed ID: 15611240
[TBL] [Abstract][Full Text] [Related]
9. The NF-kappa B cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes.
Khoshnan A; Tindell C; Laux I; Bae D; Bennett B; Nel AE
J Immunol; 2000 Aug; 165(4):1743-54. PubMed ID: 10925251
[TBL] [Abstract][Full Text] [Related]
10. Retroviral transduction of human peripheral blood lymphocytes with Bcl-X(L) promotes in vitro lymphocyte survival in pro-apoptotic conditions.
Eaton D; Gilham DE; O'Neill A; Hawkins RE
Gene Ther; 2002 Apr; 9(8):527-35. PubMed ID: 11948378
[TBL] [Abstract][Full Text] [Related]
11. CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-xL, and IL-2 expression in primary human CD4 T lymphocytes.
Parry RV; Rumbley CA; Vandenberghe LH; June CH; Riley JL
J Immunol; 2003 Jul; 171(1):166-74. PubMed ID: 12816995
[TBL] [Abstract][Full Text] [Related]
12. CD28 ligation induces transplantation tolerance by IFN-gamma-dependent depletion of T cells that recognize alloantigens.
Yu XZ; Albert MH; Martin PJ; Anasetti C
J Clin Invest; 2004 Jun; 113(11):1624-30. PubMed ID: 15173889
[TBL] [Abstract][Full Text] [Related]
13. CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response.
Radvanyi LG; Shi Y; Vaziri H; Sharma A; Dhala R; Mills GB; Miller RG
J Immunol; 1996 Mar; 156(5):1788-98. PubMed ID: 8596028
[TBL] [Abstract][Full Text] [Related]
14. Cutting edge: distinct TCR- and CD28-derived signals regulate CD95L, Bcl-xL, and the survival of primary T cells.
Kerstan A; Hünig T
J Immunol; 2004 Feb; 172(3):1341-5. PubMed ID: 14734708
[TBL] [Abstract][Full Text] [Related]
15. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL.
Boise LH; Minn AJ; Noel PJ; June CH; Accavitti MA; Lindsten T; Thompson CB
Immunity; 1995 Jul; 3(1):87-98. PubMed ID: 7621080
[TBL] [Abstract][Full Text] [Related]
16. CD28/B7 regulation of anti-CD3-mediated immunosuppression in vivo.
Tang Q; Smith JA; Szot GL; Zhou P; Alegre ML; Henriksen KJ; Thompson CB; Bluestone JA
J Immunol; 2003 Feb; 170(3):1510-6. PubMed ID: 12538715
[TBL] [Abstract][Full Text] [Related]
17. Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death.
Boussiotis VA; Lee BJ; Freeman GJ; Gribben JG; Nadler LM
J Immunol; 1997 Oct; 159(7):3156-67. PubMed ID: 9317113
[TBL] [Abstract][Full Text] [Related]
18. 4-1BB costimulation of effector T cells for adoptive immunotherapy of cancer: involvement of Bcl gene family members.
Kroon HM; Li Q; Teitz-Tennenbaum S; Whitfield JR; Noone AM; Chang AE
J Immunother; 2007; 30(4):406-16. PubMed ID: 17457215
[TBL] [Abstract][Full Text] [Related]
19. A point mutation in CD28 distinguishes proliferative signals from survival signals.
Okkenhaug K; Wu L; Garza KM; La Rose J; Khoo W; Odermatt B; Mak TW; Ohashi PS; Rottapel R
Nat Immunol; 2001 Apr; 2(4):325-32. PubMed ID: 11276203
[TBL] [Abstract][Full Text] [Related]
20. Peripheral deletion after bone marrow transplantation with costimulatory blockade has features of both activation-induced cell death and passive cell death.
Wekerle T; Kurtz J; Sayegh M; Ito H; Wells A; Bensinger S; Shaffer J; Turka L; Sykes M
J Immunol; 2001 Feb; 166(4):2311-6. PubMed ID: 11160287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
